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Modulation of Monocyte-Derived Dendritic Cell Maturation and Function by Cigarette  
 
Smoke Condensate in a Bronchial Epithelial Cell Co-Culture Model 
 
Alison J. Montpetit 
 
ABSTRACT 
 
 Lung airway epithelium is the first line of defense against inhaled particulates 
such as cigarette smoke.  Subepithelial dendritic cells (DC) survey the airway epithelial 
lining and represent the link between innate and adaptive immune response.  No study 
has investigated the effect of cigarette smoke on DC in the presence of epithelial cells 
(EC).  The purpose of this 4x2 factorial design study was to co-culture normal human 
bronchial epithelial (NHBE) cells with monocyte-derived dendritic cells (MDDC) and 
examine the effect of cigarette smoke condensate (CSC) and poly I:C stimulation (TLR3 
ligand that mimics viral infection) on MDDC homotypic clustering, phagocytosis ability, 
surface marker expression, DC cytokine response, T cell (TC) proliferation and TC 
cytokine response.  Experiments were performed with MDDC and TC derived from four 
individual donors.  Two planned comparisons (DMSO vehicle control compared to CSC 
high dose in both the no poly I:C and poly I:C stimulated groups) were analyzed.  In 
MDDC stimulated with CSC, there was a significant increase in homotypic clustering, 
reduced phagocytosis, increased CD54, increased CD83 and CD86 maturation marker 
expression.  Although no significant changes were observed in MDDC cytokine 
production, IL10 exhibited a trend to increase with CSC exposure but failed to reach 
statistical significance.  Despite evidence that CSC exposed MDDC are maturing, there 
was no increase in TC proliferation; however in poly I:C stimulated co-cultures, CSC 
x 
exposure increased IL2, IL5, IL10 and IL13 expression while non-stimulated co-cultures 
exhibited an increase in IL10 following CSC exposure.  This study indicates that 
cigarette smoke has the ability to decrease phagocytosis ability of DC and increases co-
stimulatory maturation markers without inducing TC proliferation and potentiating a Th2 
environment.  These findings suggest that DC of smokers may be less likely to mount a 
normal immune response to invading pathogens thus providing evidence for smoker 
susceptibility to infection and how DC of smokers may respond to viral infection.  In 
addition, these findings are particularly important in patients with allergic airway disease 
since increasing Th2 cytokines would increase the risk for disease exacerbation.  
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Chapter One 
Introduction 
 Cigarette smoking has been identified as the most important cause of 
preventable morbidity and mortality in the United States.  Over 438,000 Americans die 
annually from diseases directly related to smoking (American Lung Association, 2006).  
In the United States, conservative estimates of the economic burden due to smoking are 
$167 billion in direct healthcare costs, $92 billion in lost productivity and $75 billion in 
excess medical expenditures (American Lung Association, 2006).  Approximately 8.6 
million Americans have at least one serious illness caused by smoking (American Lung 
Association, 2006).   
  For people suffering with lung disease, breathing is often a daily challenge.  
Symptom management of lung disease is a vital component of therapy.  Relieving 
dyspnea and breathlessness by encouraging smoking cessation is one of the most 
effective strategies.  Despite efforts of nurses and other health care professionals to 
educate smokers of the risk of pulmonary disease, many continue to smoke and 
approximately 15 billion cigarettes are smoked worldwide every day (American Lung 
Association, 2003).  In addition, over 50% of teenagers aged 13-15 who claim to have 
never smoked are exposed to secondhand smoke in the home (Centers for Disease 
Control and Prevention, 2007).  There is a need to conduct research that explores 
immune responses to cigarette smoke and potential use of immune modulating 
therapies and their effects on the pulmonary system in smokers and nonsmokers.  
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  Lung airway epithelium is the first line of defense against inhaled particulates 
such as cigarette smoke and represents a component of the innate immune response.  
Dendritic cells (DC) in the respiratory tract are professional antigen presenting cells that 
reside within the epithelium, submucosa and lung parenchyma (Lambrecht & Hammad, 
2003; Upham & Stick, 2006).  One function of the DC is to survey the lung environment 
for antigens, microbes and dead or dying cells (Rossi & Young, 2005).  DC also link the 
innate immune response with the adaptive immune response and play a key role in not 
only antigen presentation but also in determining Th1 and Th2 immune responses.  
Cigarette smoke has been shown to suppress DC function and lead to an induction of 
Th2 immune response thus potentiating the allergic response (Vassallo & Chen, 2004; 
Vassallo, Tamada, Lau, Kroening, & Chen, 2005).   In addition, the crosstalk between 
epithelial cells (EC) and DC has been shown to be especially important in airway 
inflammation and asthma (Lambrecht & Hammad, 2003; Upham & Stick, 2006). 
  Several studies have shown that smokers and people exposed to secondhand 
smoke are at increased risk for infections (Carroll et al., 2007) and at high risk for the 
development of chronic obstructive pulmonary disease (COPD) and asthma (Goodwin, 
2007; Halken, 2004; Teramoto, 2007).  Asthmatics who smoke are less responsive to 
corticosteroid therapy than non-smoking asthmatics (Thomson, Shepherd, Spears, & 
Chaudhuri, 2006), making treatment of patients who smoke quite challenging for health 
care providers.  In addition, patients with asthma and/or COPD who smoke or are 
exposed to secondhand smoke are more prone to disease progression and exacerbation 
(Alvarez, Schulzer, Jung, & Fitzgerald, 2005; Eisner & Iribarren, 2007; Eisner et al., 
2005; Kanner, Anthonisen, & Connett, 2001; Koga, Oshita, Kamimura, Koga, & Aizawa, 
2006; Wark & Gibson, 2006). 
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  Lung disease exacerbation is linked with a decline in lung function, decreased 
quality of life and increased morbidity and mortality (Bai, Vonk, Postma, & Boezen, 2007; 
Cote, Dordelly, & Celli, 2007; Donaldson, Seemungal, Bhowmik, & Wedzicha, 2002; 
Rogers, Adelroth, Hattotuwa, Dewar, & Jeffery, 2007).  Studies indicate that cigarette 
smoke has the ability to modulate the immune response most likely, dampening the Th1 
type immune response and favoring a Th2 type immune response.  Despite recent 
advances in research related to the immune response to cigarette smoke exposure, the 
exact mechanisms of smoker vulnerability remains unclear. 
  One possible explanation for the increased risk of infection, inflammation and 
exacerbation of pulmonary disease in smokers is that smokers have fewer numbers of 
DC in the bronchial mucosa.  This finding was observed in bronchial biopsies of patients 
with COPD who smoke compared with non-smoking normal, asthmatic and COPD 
controls (Rogers et al., 2007).  In addition, one study reported observing significantly 
less CD83+ mature DC in the airways of smoking asthmatics when compared to non-
smoking asthmatics and healthy non-smoking controls (Tsoumakidou et al., 2007).  This 
phenomenon has also been observed in cord blood from neonates of smoking mothers 
(Pachlopnik Schmid et al., 2007).  This study reported a significant decrease in all 
leukocytes including CD11c+ myeloid and CD123+ lymphoid DC.  By decreasing the 
number of DC in the airways, the innate immune system's ability to respond is hindered; 
however, the potential mechanism requires further inquiry as this observation may 
merely be explained by migration of DC to the lymph nodes, other tissues or down-
regulation in surface marker expression. 
  Despite overwhelming evidence that smoking is harmful, it cannot be ignored that  
evidence suggests a protective effect of tobacco smoking against certain diseases 
including, but not limited to: Parkinsons' and Alzheimer's disease (Fratiglioni & Wang, 
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2000), sarcoid arthritis (Visser et al., 2002), and ulcerative colitis (Mahid, Minor, Soto, 
Hornung, & Galandiuk, 2006).  Interestingly, these diseases have an inflammatory or 
autoimmune component and particulates in cigarette smoke and/or nicotine may 
suppress the immune response and potentially protect against these diseases.  Overall, 
it is clear that cigarette smoking modulates the immune system by activation and 
suppression making research inquiry complex. 
  People who smoke face often face challenges in the life-dependent act of 
breathing.  Nursing care is guided toward symptom assessment and management as 
well as playing a critical role in educating patients and family regarding symptom 
management, smoking cessation, disease pathophysiology and progression, and 
prevention of exacerbations. 
  No study has investigated the effect of cigarette smoke in DC in the presence of 
epithelial cells (EC).  By specifically studying the interaction of DC and EC exposed to 
cigarette smoke particulates, this study will provide focused insight into the immune 
effects of smoke and the link between innate and adaptive immunity.  This will add to the 
body of knowledge regarding smoke immunomodulation enabling nurses and other 
health care providers to improve current methods of diagnosis, symptom management 
and monitoring in order to prevent disease exacerbation.   In chapter two, a review of the 
literature will be presented in order to further develop the concepts to be investigated in 
this study.   
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Chapter Two 
Review of Literature 
 Bronchial Epithelial Mucosa as First Line of Defense 
  Bronchial EC play a critical role in protecting submucosal tissue from inhalation 
injury by entrapment and removal of particulates by mucous secreting goblet cells, 
ciliated cells, and intact tight junctions.  Although this is a key function of the bronchial 
lining, recent advances in immunology research have indicated that EC play an 
important role in linking the innate and adaptive immune systems.  This is evident in the 
ability of EC to secrete cytokines and chemokines in response to inhaled allergens, 
pollutants and chemicals that lead to inflammatory cell recruitment, airway remodeling 
and development or potentiation of airway disease such as asthma, emphysema and 
chronic bronchitis (Gershwin, 2007; Kato & Schleimer, 2007; Lambrecht & Hammad, 
2003; Schleimer, Kato, Kern, Kuperman, & Avila, 2007; Upham & Stick, 2006). 
  The immune system is composed of two major branches: innate and adaptive 
immunity.  The innate immune response is the body's first line of defense against 
infection and hinges on the ability to recognize self from non-self.  EC in the pulmonary 
system are heavily equipped with numerous systems that protect the body from 
microbial, viral, chemical and particulate invasion.  Some of these mechanisms include 
but are not limited to the complement system, collectins, mucins, reactive oxygen 
species and toll-like receptors (Ezekowitz & Hoffman, 2003; Schleimer et al., 2007).  In 
addition to the innate immune system, EC play a role in the adaptive immune system.  
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The adaptive immune system response is characterized by antigen 
processing/presentation and induction of a memory response to specific antigens and 
involves many cells including T and B cells.  This review will focus primarily on one type 
of antigen presenting cell, DC. 
 
 Dendritic Cells:  The Professional Antigen Presenting Cell  
  DC represent 1-2% of peripheral blood mononuclear cells and approximately 
0.5% of cells found in bronchoalveolar lavage fluid (BALF) (Donnenberg & Donnenberg, 
2003; Tsoumakidou, Tzanakis, Papadaki, Koutala, & Siafakas, 2006; van Haarst et al., 
1994).  In humans, there are two major types of DC, myeloid (mDC) and plasmacytoid 
(pDC).  Myeloid DC express the surface marker CD11c and capture antigen by 
phagocytosis and macropinocytosis.  Plasmacytoid DC are derived from a lymphoid 
lineage, do not express CD11c and are inefficient in phagocytosis (Schuurhuis, Fu, 
Ossendorp, & Melief, 2006).  Both mDC and pDC have the ability to induce Th1 and Th2 
type responses but the response is primarily determined by environmental stimuli such 
as pulmonary inflammation.   
 Both types of DC exist in the lungs; however, mDC are predominate and they are 
located in the conducting airway, interstitium and alveoli (de Heer, Hammad, Kool, & 
Lambrecht, 2005; Iwasaki, 2007).  One study reported 0.06% of pDC in BALF and 
0.47% mDC and demonstrated an increase in both pDC and mDC following a segmental 
allergen challenge (Bratke et al., 2007).  In addition, one study investigated DC in lung 
digests and the presence of blood DC antigen (BDCA), a marker used to subtype blood 
DC.  This study showed four subtypes of DC in the lungs: mDC1 (BDCA1+/HLA-DR+), 
mDC2 (BDCA3+/HLA-DR+), pDC (BDCA2+/CD123+) and CD1a+ DC in the conducting 
airway epithelium (Demedts, Brusselle, Vermaelen, & Pauwels, 2005).  Another study 
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confirmed the presence of the three subtypes (mDC1, mDC2, pDC) in BALF 
(Tsoumakidou et al., 2006).  It is apparent that with advances in flow cytometry 
techniques and identification of surface markers, more pulmonary DC subtypes will be 
elucidated.   
 DC are key in directing immune responses throughout the body, but for the 
purposes of this review, only pulmonary DC are examined.  In the lungs, DC are located 
within the lung epithelium and interstitium and perfectly placed for sampling the bronchial 
airway for inhaled antigens and particulates (Grayson, 2006; Lambrecht, Prins, & 
Hoogsteden, 2001).  Studies have shown that DC that reside underneath and within the 
epithelium are able to extend their dendrites through epithelial tight junctions in order to 
sample the airway.  The DC then migrate to draining lymph nodes where they confer 
antigen-specific responses.  Pulmonary inflammation plays a key role in the maturation 
process and trafficking of DC.   
  Immature DC phagocytose/endocytose bacteria, allergens, pollutants and 
cellular debris in the airway.  They then process the antigen and carry immune signals 
from the periphery or site of capture to the secondary lymphoid tissue where, after 
maturation, they present antigen to TC (Cook & Bottomly, 2007).  Pulmonary DC are the 
sentinels of the lung and they direct clonal expansion of TC by cross-presentation of 
allergens to CD4+ T helper cells, CD8+ cytotoxic TC and are the only cells capable of 
priming naïve TC (Cools, Ponsaerts, Van Tendeloo, & Berneman, 2007; Novak & 
Bieber, 2008).   
 The response of naive T helper cells after contact with pathogen-specific, mature 
DC is determined by three main signals: 1) antigen specific (by engagement of the TC 
receptor by MHC class II), 2) co-stimulation and 3) polarization.  Signal 1 is 
characterized by antigen specificity.  Signal 2 provides protective immunity by co-
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stimulatory molecules and if signal 2 is not present, it leads to TC anergy and potentially 
tolerance.  Signal 3 is important in determining the balance of cytokine production from 
primed TC.  There is a functional difference in DC and TC depending on the micro-
environment of the third signal.  It is unclear where all of these third signals originate but 
the micro-environment, character of antigen, and the affected tissue all play a critical 
role.  Since DC are in close proximity to EC, it is hypothesized that polarizing signals 
may be driven by EC (Kalinski, Hilkens, Wierenga, & Kapsenberg, 1999; Kapsenberg, 
2003; Schuurhuis et al., 2006). 
 Naïve TC generally have four broad fates including: Th1, Th2, Th17 and Treg.  
For the purposes of this review, only CD4+ TC subsets will be discussed.  Th1 is 
primarily characterized by IFNγ and TNFα release; Th2 is primarily characterized by IL4, 
IL5 and IL13 release, Th17 by IL17 and Treg by IL10 and TGFβ.  An imbalance towards 
one type has been implicated in many diseases for example, Th1 in autoimmune 
diseases, Th2 in allergic diseases, Th17 in chronic inflammatory and autoimmune 
disorders and Treg in cancer and immunosuppression (Hammad & Lambrecht, 2006; 
Romagnani, 2006).   
 Many antigens induce DC maturation following uptake resulting in TC activation; 
however, most antigens fail to induce maturation requiring secondary signals from the 
micro-environment (Kalinski et al., 1999; Kapsenberg, 2003).  This is a critical balance 
since approximately 10,000 L of air circulate through the lungs every day exposing EC 
and DC to many particles (Cook & Bottomly, 2007).  In fact, the outcome of inhalation of 
most harmless antigens results in tolerance.  Under steady state conditions, DC remain 
in an immature or semi-mature state during which they are continue to phagocytize 
antigen and have high expression of receptors for pro-inflammatory chemokines and 
cytokines (Novak & Bieber, 2008).   This active process is characterized by tolerogenic 
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DC presenting antigen to naïve TC which in turn acquire regulatory TC (Treg) properties 
including Foxp3+, production of IL10 and TGFβ, the ability to suppress Th1 and Th2 
processes.  There is some debate about characteristics of tolerogenic DC but generally 
these DC are considered semi-mature, are inefficient at phagocytosis of antigen, 
produce IL10 and are less motile but may express maturation/co-stimulatory molecules 
(Cook & Bottomly, 2007; Morelli & Thomson, 2007; Reis e Sousa, 2006; Steinman, 
Hawiger, & Nussenzweig, 2003).   
  
Epithelial and Dendritic Cell Interaction 
  EC are the first contact with inhaled particulates and they play a critical role in 
regulation of immune responses through interactions with DC, TC and B cells among 
others.  This review will focus specifically on EC and DC interactions.  EC may play a 
role in recruitment of DC into the airways via macrophage inflammatory protein 3 alpha 
also known as chemokine (C-C motif) ligand 20 (CCL20) and possess the ability to 
polarize DC to a Th1 or Th2 directing phenotype (Kao et al., 2005; Thorley, Goldstraw, 
Young, & Tetley, 2005).  One example, EC-derived thymic stromal lymphopoietin (TSLP) 
secretion directs DC to activate naïve TC to Th2 cells that produce IL4, IL3, TNF but not 
IL10 or IFNγ (Kato, Favoreto, Avila, & Schleimer, 2007; Lee & Ziegler, 2007; Liu et al., 
2007). 
  One example of the importance of EC-DC interaction is shown by the effect of 
diesel exhaust particulates (DEP) to induce DC maturation marker CD80, CD83, CD86 
and TC proliferation when DC and EC are co-cultured and this effect is not observed 
when DC are cultured alone (Bleck, Tse, Jaspers, Curotto de Lafaille, & Reibman, 
2006).  In this study, supernatant from DEP-exposed EC induced DC maturation and 
was equivalent to DC cultures with DEP-exposed EC, suggesting that soluble mediators 
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rather than direct cell-to-cell contact are critical for DC maturation and function.  In 
addition, when a blocking antibody (Ab) and short interfering RNA (siRNA) to the growth 
factor, granulocyte-macrophage colony-stimulating factor (GMCSF) was administered to 
DEP-exposed EC cultures, DC failed to induce TC proliferation (Bleck et al., 2006).  This 
finding suggests the critical role of EC-derived GMCSF in DC maturation and function.  
This study did not evaluate the cytokine production of TC from the MLR; therefore, it is 
unknown if DEP-exposed EC co-cultured with DC induce TC to produce Th1 or Th2 
cytokines.  Based upon this study, it is reasonable that cigarette smoke-exposed EC 
culture may modulate patterns of DC maturation and TC proliferation when cultured with 
DC since cigarette smoke and DEP are both pro-inflammatory and potent oxidant 
stressors. 
  
Cigarette Smoke as an Oxidant Stressor 
  The pathogenesis of many lung diseases such as chronic obstructive pulmonary 
disease (COPD) and asthma may be a function of free oxygen radicals or oxidant 
mediators which can act as immune adjuvants, enhancing the response to inhaled 
allergens or antigens (Nouri-Shirazi & Guinet, 2006; Siafakas & Tzortzaki, 2002; Sopori, 
2002; Tsoumakidou et al., 2007).  A number of environmental stimuli or oxidant 
mediators induce cellular oxidative stress (OS) that stimulates several biological effects 
such as, increased inflammation and mucous production, decreased cilia function, 
impaired surfactant activity, promotion of epithelial permeability, inhibition of 
glucocorticoid responses and many others (Repine, Bast, & Lankhorst, 1997).  All these 
effects compromise the effectiveness of the innate immune system. 
  Conceptually, OS has been defined as a loss of balance in which oxidation 
exceeds the antioxidant systems in the body.  One cause of OS in the lungs is cigarette 
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smoke.  Cigarette smoke has approximately 1017 oxidants/free radicals and 4,800 
chemical compounds which increases the oxidant burden in smokers and the risk of 
developing pulmonary disease through chronic inflammatory processes and increasing 
airspace permeability (American Lung Association, 2006; MacNee, 2000; Marwick et al., 
2002; Moodie et al., 2004).  The respiratory tract is extremely differentiated and its ability 
for gas exchange is dependent on thin epithelial cell membranes in the respiratory tract 
and are the first contact with air particulates, making them more susceptible to the 
environment and cigarette smoke than other tissues; thus, they are more vulnerable to 
reactive oxygen species that can cause cellular damage and alter in the immune 
response by increased susceptibility to inflammation and infection (Jyonouchi, 1999; 
Lambre et al., 1996).   
 
Effects of Cigarette Smoke on Humans in vivo 
 Several studies have investigated the effect of cigarette smoke in humans.  
Smokers have dramatically fewer numbers of DC in the bronchial mucosa which was 
observed in bronchial biopsies of patients with COPD who smoke compared with non-
smoking normal, asthmatic and COPD non-smoking controls (Rogers et al., 2007).  In 
fact, COPD ex-smokers had similar numbers of DC as asthmatics; therefore, the 
reduction in DC is not a function of the disease process.  The location of these DC were 
determined by transmission electron microscopy images which revealed the presence of 
DC primarily in the bronchial mucosa epithelium and subepithelium (Rogers, Adelroth, 
Hattotuwa, Dewar, & Jeffery, 2008).   
 One study reported significantly less CD83+ mature DC in the bronchial biopsies 
of smoking asthmatics compared to non-smoking asthmatics and healthy non-smoking 
controls (Tsoumakidou et al., 2007).  However, another study did not find a difference in 
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CD83+ DC in bronchoalveolar lavage fluid (BALF) of smokers versus never smokers.  
They did observe a difference in CD80+ and CD86+ DC in smokers.  In addition, they 
reported decreased expression of CCR7, a lymph node homing receptor that is 
important in migration, suggesting that the reduction in DC is not due to DC migration.  
 In a randomized, placebo-controlled trial, non-smoking allergic subjects were 
exposed to two hours of environmental tobacco smoke (ETS) or clean air then subjected 
to a nasal challenge with ragweed allergen or saline and nasal lavages were obtained.  
Twenty-four hours after ETS exposure with allergen challenge, there was a significant 
increase in ragweed-specific IgE, histamine, IL4, IL5 and IL13 and a significant reduction 
in IFNγ, when compared with clean air exposure with allergen challenge (Diaz-Sanchez, 
Rumold, & Gong, 2006).  This study was the first to show evidence in humans that 
cigarette smoke can directly exacerbate allergic disease. 
 
Effects of Cigarette Smoke on Murine Dendritic Cells in vivo 
 Several studies have investigated the effect of smoke in murine models.  One 
study exposed mice to two cigarettes per day, five days a week for two months.  They 
reported a significant decrease in the number of CD11c+/MHC-II+ in smoke exposed 
mice compared with controls.  In addition, this trend preceded emphysematous lesions 
in the lungs and was lung specific as there was no reduction in DC in regional lymph 
nodes (Robbins et al., 2004).  This provides evidence that smoke effects on lung DC are 
not merely a result of DC migration.   
 Another murine study where mice were exposed to 6 cigarettes a day, five days 
a week for one month confirmed this reduction in pulmonary CD11c+ DC and reported 
that antigen induced migration to draining lymph nodes was not affected by smoke 
exposure.  In addition, they reported a reduction in MHC-II, CD80 and CD86 but no 
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effect on CD40 in DC within the lymph nodes.  They also observed a reduction in TC 
proliferation and significantly less CD4+ TC IL2 production from smoke exposed mice 
when compared to control (Robbins, Franco, Mouded, Cernadas, & Shapiro, 2008).   
   
Effects of Cigarette Smoke on Human Dendritic Cells in vitro 
  Clinical evidence described previously suggests that smokers are more prone to 
Th2 type response.  Since DC have the ability to sample the bronchial airway, take up 
smoke particulates and are key mediators of immune response, it is reasoned that DC 
function and DC-induced TC response may be affected by cigarette smoke.  Only two 
studies have evaluated the effects of cigarette smoke on human DC function. 
  The first study investigated the role of cigarette smoke extract (CSE), the 
particulate phase of smoke on DC co-stimulatory markers (CD40, CD80, CD83, CD86), 
TC proliferation (BrdU assay) and polarization of TC cytokine response (IL2, IL4, IL10, 
IFNγ).  This study provided evidence that CSE suppresses maturation markers (CD40, 
CD80, CD86) and suppresses IL12 and enhances IL10 production.  In addition, CSE-
exposed DC inhibit TC proliferation and promote Th2 (IL4) cytokine release from TC.  
Together, this suggests that smoke suppresses DC functions and potentiates a Th2 
response (Vassallo et al., 2005).   
  The second study investigated TC proliferation (CFSE assay) and cytokine 
response (IL12p70, IL4, IFNγ) in response to DC cultured with nicotine and matured 
under non-polarized or polarized Th1 and Th2 conditions (Nouri-Shirazi & Guinet, 
2006).  The study provided evidence that nicotine exposed DC are able to induce TC 
proliferation but not Th2 differentiation (IL4 secretion) unless under a Th2 polarizing 
condition described as exposure to IL1β, TNFα and prostaglandin E2. 
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  In these two studies, DC were cultured alone.  As discussed previously, DEP-
treated DC did not induce TC proliferation when DC were cultured alone.  This is the 
same observation with cigarette smoke in the first study but not in the nicotine study.  
This discrepancy may be a function of particulates in smoke-exposed EC.  It has been 
shown that smoke-exposed bronchial EC produce pro-inflammatory cytokines including, 
IL6 and IL8; however, it has also been shown that smoke induces downregulation of 
GMCSF in lippolysaccaride (LPS)-treated EC (Glader et al., 2006; Li, Xu, & Shen, 2007; 
Phillips, Kluss, Richter, & Massey, 2005).  GMCSF was shown to have significant effects 
on DC maturation in DEP-exposed co-cultures of DC and EC (Bleck et al., 2006). 
  By culturing DC with smoke-exposed EC, it will take into account the impact of 
the tissue micro-environment on environmental exposures.  Therefore, the proposed 
study will provide insight into EC-DC interactions in smoke exposure and may provide 
evidence for disease and infection susceptibility in cigarette smokers. 
  
Polyinosinic-Polycytidylic Acid as an Immunological Stimulant 
  A major signal for DC priming are toll-like receptors (TLR) which are highly 
conserved immune receptors responsible for recognition of pathogen-associated 
molecular patterns (PAMP) of bacteria and viruses thereby initiating the immune 
response (Duez, Gosset, & Tonnel, 2006; Guillot et al., 2005; Kapsenberg, 2003).  
Specifically, TLR3 recognizes double stranded RNA (dsRNA) of viruses such as 
influenza and rhinovirus and induces a potent antiviral response (Doyle et al., 2003; 
Guillot et al., 2005; Hewson, Jardine, Edwards, Laza-Stanca, & Johnston, 2005).  In both 
epithelial and monocyte-derived DC, TLR3 is primarily located in the cytoplasm and 
endoplasmic vesicles (Ciencewicki, Brighton, Wu, Madden, & Jaspers, 2006; Duez et al., 
2006). 
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  Poly I:C (Figure 1)  is a TLR3 ligand and a dsRNA that mimics the effects of viral 
infections (Marshall-Clarke et al., 2007).  EC stimulated with poly I:C have been shown 
to up-regulate numerous pro-inflammatory cytokines (IL1β, IL6), growth factor (GMCSF), 
chemokines (IP10, IL8) and adhesion molecules such as ICAM-1 (Matsukura et al., 
2006; Ritter, Mennerich, Weith, & Seither, 2005).  DC stimulated with poly I:C exhibit 
stable maturation and produce high levels of IL12, low levels of IL10 and a strong TC 
proliferative response (Verdijk et al., 1999).  In addition, poly I:C-stimulated DC retain the 
ability to produce IL12p70 even after the initial maturation stage, thus driving a Th1 
response (Rouas et al., 2004; Verdijk et al., 1999). 
  One study revealed that diesel exhaust enhanced poly I:C-induced expression of 
TLR3, interferon beta and IL6 in lung EC providing mechanistic evidence that inhalation 
of particulates affect the immune response to viral infection (Ciencewicki et al., 2006).  
Dysregulation of the innate immune response could lead to enhancement of 
inflammatory cell recruitment, DC activation, adaptive immune response and potentially 
an auto-immune or allergic type reaction.  No studies have been conducted investinging 
modulation of poly I:C effects by cigarette smoke; however, it is important to determine if 
smoke down-regulate cytokine production and push the Th2 response despite the Th1 
poly I:C effects.  This will mimic the clinical scenario of cigarette smokers exposed to 
viral infection. 
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Figure 1.  Structure of poly I:C.  Reprinted from (Chemblink.com, 2007) with permission. 
  
 It is evident that smoke modulates the immune response and impacts disease 
development and progression.  Unfortunately, the exact mechanism by which this occurs 
remains unclear.  By culturing MDDC with smoke-exposed NHBE, it takes into account 
the impact of the tissue micro-environment on the response of MDDC.  This study 
provides insight into EC-DC interactions in smoke exposure and may provide evidence 
for disease and infection susceptibility in cigarette smokers.  In addition, by investigating 
the effect of smoke in poly I:C stimulated co-cultures, this study also provides insight into 
how a smoker may respond to viral infection.  In chapter three, the purpose, models and 
methods of this study is described.   
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Chapter Three 
Method 
Purpose 
 The purpose of this preliminary 4x2 factorial design study was to examine the 
effect of cigarette smoke condensate (CSC) on monocyte derived DC (MDDC) 
clustering, cytokine response, maturation, endocytosis ability, TC proliferation and 
polarization.  This study was guided by the conceptual model in Figure 2.  This concept 
model shows the in vitro model model (NHBE, MDDC co-culture), four levels/doses 
(control/resting, DMSO/vehicle control, 10 μg/ml and 50 μg/ml) of cigarette smoke 
condensate (CSC) exposure, two levels/doses (0 and 25 μg/ml) of poly I:C stimulation.  
The dashed arrows and box, indicates the theoretical concept of DC maturation and 
function followed by the categories of dependent variables to be measured.   
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Figure 2.  Conceptual model.  In vitro study of CSC and poly I:C modulation of dendritic cell 
maturation and function in NHBE cell and MDDC co-culture model, DMSO = dimethyl sulfoxide.   
  
Hypothesis 
  It was hypothesized that CSC will suppresses DC maturation and redirect DC-
induced CD4+ T lymphocyte differentiation, leading to augmentation of T helper type 2 
(Th2) cytokine secretion.  The working model (Figure 3) depicts the innate and adaptive 
immune responses following exposure to CSC.  EC up-regulate cytokine secretion and 
MDDC take up CSC particulates, modulating maturation and function.  Stimulated 
MDDC undergo functional maturation and secrete T helper lymphocyte Th2 polarizing 
type cytokines.  Theoretically, the DC then migrate to the lymph nodes (LN), promoting 
differentiation and proliferation of CD4+ TC into Th2 cells linking the innate immune 
response with the adaptive immune response. 
 
Dependent VariablesIndependent VariablesModel 
CSC Exposure: 
1-Control (resting cells) 
2-DMSO (vehicle control) 
3-CSC low dose (10 μg/ml) 
4-CSC high dose (50 μg/ml) 
Poly I:C Stimulation: 
1-No stimulation (medium) 
2-With stimulation (25 μg/ml) 
MDDC                   
Viability 
Homotypic Clustering 
Phagocytosis              
Cytokines               
Surface Markers
MDDC  
Maturation  
Function 
NHBE         
MDDC  
co-culture 
TC                      
Proliferation 
Cytokines 
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Figure 3. Working model.  Depicts CSC exposed co-culture of EC and MDDC. 
  
Specific Aims and Research Questions 
 This proposed study has two main aims.  The first objective was to characterize 
the co-culture model and exposure systems and to determine the effect of cigarette 
smoke exposure and poly I:C stimulation on MDDC viability, homotypic clustering and 
cytokine secretion.  The second objective was to determine the effect of cigarette smoke 
exposure and poly I:C stimulation on MDDC surface marker expression and 
phagocytosis.  In addition, the effect of CSC exposed and poly I:C stimulated MDDC on 
TC proliferation and polarization was examined through mixed lymphocyte reaction and 
cytokine analysis. 
 
 
to LN 
Innate 
DC
MDDC 
T
EC 
Adaptive 
Th2 polarization
MDDC 
CSC 
20 
Specific aim 1.   Characterize and optimize CSC exposure and poly I:C stimulation 
of the NHBE cells, MDDC and a co-culture of NHBE cells and MDDC (Figure 4)  
•  Can NHBE cells, MDDC and the co-culture model be cultured effectively? 
•   Is there a difference in homotypic clustering of MDDC co-cultured with NHBE 
cells following exposure to CSC and poly I:C stimulation? 
•   What are the cytokine profiles of NHBE cells and MDDC co-cultured with NHBE 
cells following exposure to CSC and poly I:C stimulation? 
•   Does CSC exposure modulate poly I:C-stimulated cytokine/chemokine/growth 
factor expression of NHBE cells and MDDC co-cultured with NHBE cells? 
 
 Figure 4.  Aim 1 experimental schema.  Depicts the experimental schema for aim 1 establishing 
and characterizing the model, μg/ml = microgram per milliliter.  
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Specific aim 2.   Determine the effect of CSC and poly I:C stimulation on DC 
maturation, function and the ability of the exposed/stimulated DC to induce TC 
proliferation and priming.  Compare the response of DC cultured alone or with bronchial 
EC (Figure 5).  
•   Does CSC exposure and poly I:C stimulation induce phenotypic DC maturation 
in MDDC co-cultured with NHBE cells as evidenced by maturation markers 
(CD80, CD83, CD86, and CD54) within the CD11c+ population? 
•   Does CSC exposure and poly I:C stimulation induce functional DC maturation in 
MDDC co-cultured with NHBE cells as evidenced by a lack of endocytic ability? 
•   Do CSC-exposed and poly I:C-stimulated MDDC co-cultured with NHBE cells 
induce CD4+ TC proliferation in MLR as evidenced by the CFSE proliferation 
assay? 
•   Do CSC-exposed and poly I:C-stimulated MDDC co-cultured with NHBE cells 
induce CD4+ cell proliferation towards a Th2 phenotype in the MLR as 
evidenced by a decrease in Th1 cytokines and an increase in Th2 cytokines? 
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Figure 5.  Aim 2 experimental schema.  Depicts the experimental schema of aim 2 designed to 
test the effects of CSC and poly I:C exposure on MDDC surface marker expression, 
phagocytosis, TC proliferation and cytokine production. 
 
Materials 
Normal human bronchial epithelial cell culture.  Primary NHBE cells were chosen 
for this study since they may more accurately mimic in vivo cell division characteristics 
as compared to transformed cell lines.  NHBE cells were purchased from 
Clonetics/Cambrex (Lonza, Switzerland) which obtained the cells from healthy human 
volunteers after informed consent.  Cells from one donor were obtained for replication of 
experiments.  NHBE cells were grown according to the distributor guidelines.  Briefly, 
primary NHBE cells (Passage 1) were grown to 75-80% confluency in an atmosphere of 
5% CO2 and 95% air at 37oC.  Cell culture medium consists of bronchial epithelial 
growth medium supplemented with bovine pituitary extract, insulin, hydrocortisone,  
NHBE  
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Dose (0, DMSO, 10, 
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Time (12 hours) 
Model 
Poly I :C Stimulation 
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(MLR) 
Time (4-5 days) 
TC  
Proliferation 
Cytokine Analysis  
NHBE + MDDC 
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Time (24 hours) 
MDDC  
Surface Markers 
Phagocytosis 
Independent 
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Dependent 
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human epithelial growth factor, epinephrine, transferring, retinoic acid and 
triiodothyronine (Lonza, Switzerland).  Cells were subcultured, aliquoted into freezing 
tubes (50,000 cells/vial), and stored in liquid nitrogen following passage 1.  Cells used in 
these experiments were at a passage of 2 and 3.  For NHBE only experiments, NHBE 
cells were seeded onto 12 well plates and grown to confluency.  Confluent cultures will 
be exposed to CSC depending on experimental group (0, 10 or 50 μg/ml) for 12 hours.  
Poly I:C was then be added to CSC-conditioned medium depending on experimental 
group (0 or 50 μg/ml) for 1-2 hours.  Following CSC exposure and poly I:C stimulation, 
DC were added to NHBE cultures.  Supernatants were collected for subsequent cytokine 
analysis. 
  
Monocyte-derived dendritic cells culture.  Peripheral blood monocytes (PBMC) 
were isolated from buffy coats obtained from healthy volunteers (Florida Blood Services) 
after isolation by Ficoll-Paque (GE Healthcare/Amersham Biosciences, USA) density 
gradient centrifugation.  CD14+ PBMC were isolated by positive selection using 
magnetically labeled CD14 antibodies and a magnetic separator (Miltenyi Biotec).  
PBMC can differentiate toward an immature, myeloid DC phenotype, CD11c+, HLA-
DRlo, E-cadherin-, langerin- (de Heer et al., 2005) by an established method of culturing 
with IL4 and GMCSF as described previously in the literature (Sallusto & Lanzavecchia, 
1994).  Briefly, CD14+ PBMC were cultured in RPMI 1640 medium supplemented with 
2% L-Glutamin, 1% penicillin/streptomycin and 10% fetal bovine serum, 10 ng/ml IL-4, 
20ng/ml GMCSF (Peprotech), 1% nonessential amino acids and 1% sodium pyruvate 
(Sigma).  Cultures were kept for 5-6 days in an atmosphere of 5% CO2 and 95% air at 
37oC.  Immature MDDC (iMDDC) were harvested on day 5 or 6 and characterized by 
flow cytometry. One study compared the phenotype of DC using this method with lung 
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DC and reported similar phenotypic (low expression of CD40, CD80, CD83, CD86) and 
functional patterns (high capacity for the uptake of dextran and the ability to stimulate 
TC), making this an appropriate model for the in vitro study of pulmonary DC (Cochand, 
Isler, Songeon, & Nicod, 1999).   
 
Co-culture of NHBE and MDDC cells.  Methods for the co-culture of NHBE cells 
and MDDC are based on methods described in the literature (Bleck et al., 2006).  Briefly, 
NHBE cells at passages 2 or 3 were seeded at a density of 2x104 cells/cm2 on 12-well 
culture plates and maintained in an atmosphere of 5% CO2 and 95% air at 37oC 
approximately 7 days or until 100% confluency is reached (Figure 6).   Day 5 or 6 
iMDDC were harvested and re-suspended in complete medium.  MDDC (5x105 
cells/well) to confluent NHBE cells in 12 well plates and exposed to CSC or poly I:C-
conditioned medium depending on experimental group assigned.  Following 24 hours of 
culture, light microscope images were taken with a 4x objective for homotypic clustering 
analysis and cells were harvested, washed and aliquoted for subsequent flow cytometry, 
endocytosis assay and mixed lymphocyte reactions.  In addition, supernatants were 
collected for cytokine analysis.     
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Figure 6.  Generation of the co-culture model.  A. culture of NHBE cells submerged in culture 
medium; B. exposure of confluent NHBE cells to CSC conditioned medium for 12 hours; C. 
stimulation of confluent NHBE cells with polyinosinic:polycytidylic acid (poly I:C) for 1-2 hours; D. 
addition of MDDC and co-cultured with confluent NHBE cells for 24 hours.   
  
Treatment of cell cultures with CSC.  Cigarette smoke consists of two 
components, the gas or vapor phase and smoke particulates.  This study focused on the 
effects of smoke particulates by utilizing commercially available CSC.  CSC purchased 
from Murty Pharmaceuticals (Lexington, KY, USA) was prepared by the manufacturer by 
using a Phipps-Bird 20 channel smoking machine.  The particulate matter from Kentucky 
standard cigarettes (IR3F; University of Kentucky, KY, USA) was collected on 
Cambridge glass fiber filters and the amount obtained was determined by weight 
increase of the filter.  CSC was prepared by dissolving the collected smoke particulates 
in dimethyl sulfoxide (DMSO) to yield a 4% solution (w/v).  The average yield of CSC 
was 26.1 mg/cigarette.  One ml of CSC is equivalent to 2 standard Kentucky IR3F 
cigarettes and each cigarette contains 1.3 mg of nicotine.  CSC was added to culture 
medium in two doses (0 and 50 μg/ml) for 12 hours. 
A 
C D 
B 12 hours 
1-2 hours 24 hours 
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  Treatment of cell cultures with poly I:C (Amersham Biosciences, Pittsburgh, PA, 
USA) was reconstituted in phosphate buffered saline (PBS) to 2 mg/ml by heating to 
50oC to solubilize and allowing to slowly cool to room temperature in order to ensure re-
annealing.  Poly I:C was added to cell culture medium at two doses (0 or 50 μg/ml) for 1-
2 hours.  Poly I:C stimulated cultures were a positive control from MDDC maturation and 
mimic the effects of viral infection. 
  
Homotypic clustering of DC.  Homotypic and heterotypic clustering of DC, is 
critical for antigen presentation and correlates with DC maturation (Delemarre, 
Hoogeveen, De Haan-Meulman, Simons, & Drexhage, 2001; Lehner et al., 2003).  In 
order to assess cluster formation following CSC exposure and poly I:C stimulation, an 
aggregation assay was performed prior to supernatant collection and harvesting of cells 
for flow cytometry analysis, endocytosis assay and mixed lymphocyte cultures.  The 
homotypic cluster scoring system (Table 1) is a modification of methods reported 
previously (Lehner et al., 2003; Majdic et al., 1994).  Figure 7 presents a light 
microscopy image of DC is various cluster states: single, small and large.  Small and 
large clusters were discriminated by the density/darkness and size.  In order to be 
considered large, over 75% of clusters had to be dark/dense and greater than 10 times 
the size of a single DC.  Clusters were randomly counted by two blind investigators 
utilizing an inverted light microscope with a 4X objective and average scores were 
reported.  The degree of aggregation or clustering was scored on a scale from 0 to 8 
where a score of 0 indicates less than 10% of cells were in small clusters, a score of 1 
indicates 10-50% of the MDDC were clustered in small clusters, a score of 2 indicates 
10-50% of the MDDC were clustered in large clusters, a score of 3 indicates 51-75% of 
the MDDC were in small clusters,  a score of 4 indicates 51-75% of the MDDC were in 
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large clusters, a score of 5 indicates 76-99% of the MDDC were clustered in small 
clusters, a score of 6 indicates 76-99% of the MDDC were clustered in large clusters, a 
score of 7 indicates 100% of the MDDC were clustered in small clusters, and a score of 
8 indicates 100% of the MDDC were clustered in large clusters. 
 
Table 1   
Homotypic cluster scoring system 
 
Score 
 
Percent of Clusters 
 
Size of Clusters 
 
0 
 
< 10 %  
 
small 
1 10-50% small 
2 10-50% large 
3 51-75% small 
4 51-75% large 
5 76-99% small 
6 76-99% large 
7 100% small 
8 100% large 
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Figure 7.  Homotypic cluster scoring.  Light microscopy images depicting single cells, small and 
large clusters.   
 
Quantification of cytokines by multi-plex bead assay.  Cell culture supernatants 
from all experiments were collected, centrifuged and stored at -20oC until cytokine 
analysis was completed.  Supernatant samples were analyzed using human LINCOplex 
kits (Millipore, Billerica, MA, USA) multi-plex bead technology, which allows the analysis 
of multiple cytokines from one sample.  The assay is based on characterization beads 
with a distinct emitting fluorescence pattern that are coated with capture antibodies 
specific for individual cytokines.  A total of 7 cytokines were measured in NHBE and 
MDDC supernatants; they include: interleukin 6 (IL6), IL8, IL10, IL12p70, IL13, IFNγ-
inducible protein 10 (IP10) and tumor necrosis factor alpha (TNFα).  A total of 6 
cytokines were measured in mixed lymphocyte reaction (MLR) supernatants; they 
Large cluster 
Small cluster 
Single cell 
29 
include: IL2, IL4, IL5, IL10, IL13, and IFNγ.  Table 2 depicts each cytokine and the 
experiment in which it was collected along with the basic functional classification.   
  Cytokines were measured according to the manufacturer's instructions.  Briefly, 
25 μL aliquots of medium samples were incubated with antibody coated capture beads 
for 1 hour, washed and incubated with biotin-labeled anti-human cytokine antibodies for 
2 hours at room temperature followed by incubation with streptavidin-phycoerythin for 30 
minutes.  Samples were analyzed using Luminex 100 IS System and IS 2.3 software 
(Luminex, Austin, TX, USA).  Complete culture medium was used as the blank and 
added to all standards and quality controls.  Each sample was assayed in duplicate and 
data were presented as the average.  Standard curves of known concentrations of 
recombinant human cytokines (provided by the manufacturer) were used to convert 
mean fluorescence intensities to cytokine concentration in pg/mL by using 4 or 5 
parameter logistic regression.   
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Table 2 
Cytokine and chemokine analysis 
 
Name 
 
Th1/Th2 
 
Experiment  
 
Interleukin 2 (IL2) 
 
Th1 
 
MLR 
 
Interleukin 4 (IL4) 
 
Th2 
 
MLR 
 
Interleukin 5 (IL5) 
 
Th2 
 
MLR 
 
Interleukin 6 (IL6) 
 
Pro-inflammatory 
 
NHBE+MDDC-EC 
 
Interleukin 8 (IL8) 
 
chemokine 
 
NHBE+MDDC-EC 
 
Interleukin 10 (IL10) 
 
Th2 
 
NHBE+MDDC-EC 
MLR 
 
Interleukin 12p70 (IL12p70) 
 
Th1 
 
NHBE+MDDC-EC 
 
Interleukin 13 
 
Th2 
 
MLR 
 
Interferon gamma (IFNγ) 
 
Th1 
 
MLR 
 
IFNγ-inducible protein-10 (IP10) or CXCR3 
 
Th1 Chemokine 
 
NHBE+MDDC-EC 
 
Tumor necrosis factor alpha (TNFα) 
 
Th1 or Th2 
 
NHBE+MDDC-EC 
 
 
 
Determination of viability and phenotypic maturation of MDDC by 
immunofluorescence labeling and flow cytometry.  For phenotypic characterization of 
MDDC and NHBE cells following co-culture, MDDC were discriminated from EC by 
morphology (forward and side scatter).  Flow cytometry was used to determine viability 
and the expression of cell surface maturation markers in MDDC and co-cultures of 
MDDC and NHBE cells exposed to CSC or poly I:C.  Viability was determined by the 
addition of 7-Amino-Actinomycin D, 7-AAD (BD Biosciences Pharmingen) stain to 
identify non-viable cells during immunostaining.  In order to phenotype MDDC, cells 
were stained with fluorochrome conjugated cell surface antibodies including: fluorescein 
isothiocyanate (FITC)- conjugated CD80 and CD83, phycoerythrin (PE)-conjugated 
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CD11c and CD86, allophycocyanin (APC)-conjugated HLA-DR and CD54 (BD 
Biosciences Pharmingen; Milteynyi Biotec).  Table 3 depicts surface markers used to 
phenotype mature or activated MDDC. 
  Harvested MDDC were aliquoted into two tubes at approximately 2x105 cells per 
tube and washed.  Each tube was stained with three conjugated Abs at the 
concentration recommended by the manufacturer.  After surface staining, MDDC were 
washed with and fixed in PBS containing 4% paraformaldehyde (PFA), resuspended in 
stain buffer, protected from light and refrigerated at 4oC until flow analysis was 
performed.  Flow cytometry was performed on a Becton Dickinson Canto II and LSR 
II Immunocytometry System.  Expression of cell surface markers was determined by 
average mean fluorescence intensity (MFI).  Poly I:C treatment (50 μg/ml for 24 hours) 
served as a positive control for MDDC maturation.  Unstained cells and single stained 
cells were used to determine nonspecific binding and background auto-fluorescence. 
  
  Determination of functional maturation of MDDC by endocytosis assay.  Since 
mature DC exhibit a loss of endocytic activity, an endocytosis assay was performed to 
confirm MDDC maturation.  MDDC (5x105/mL) cultured alone or in co-culture with NHBE 
cells were exposed for 24 hours to CSC, poly I:C, CSC and poly I:C or untreated.  
Following exposure, MDDC were harvested by pipetting, washed, re-suspended in 
complete RPMI medium and incubated on ice for 30 minutes.  FITC-dextran (molecular 
weight 70,000, Molecular Probes) was added at a final concentration of 1mg/mL and 
exposed MDDC were incubated for 1 hour at 37oC or on ice (background staining).  
Following incubation, cells were immediately put on ice, washed and fixed with 4% 
paraformaldehyde, re-suspended in staining buffer and analyzed by flow cytometry (BD 
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FACS Canto).  Immature MDDC will endocytose the FITC-dextran and mature MDDC 
will not.  Data were expressed as MFI after subtracting for background staining. 
 
 Table 3  
Dendritic cell surface marker analysis.  Biological markers used for dendritic cell characterization 
 
Marker 
 
Immature 
 
Mature 
 
Function 
 
Class 
 
CD11c 
 
 
+++ 
 
+++ 
 
dendritic cell marker 
 
phenotypic 
 
HLA-DR 
 
 
++ 
 
+++ 
 
T cell receptor ligand 
 
phenotypic 
 
CD80 
 
+ 
 
+++ 
 
co-stimulatory molecule 
 
phenotypic 
 
 
CD83 
 
+ 
 
++ 
 
co-stimulatory molecule 
 
phenotypic 
 
 
CD86 
 
+ 
 
+++ 
 
co-stimulatory molecule 
 
phenotypic 
 
 
CD54 (ICAM1) 
 
 
++ 
 
+++ 
 
adhesion molecule 
 
phenotypic 
 
Phagocytosis 
 
 
+++ 
 
-- 
 
antigen uptake 
 
functional 
 
MLR  
 
-- 
 
+++ 
 
T cell proliferation 
 
functional 
 
Note. CD = cluster of differentiation; HLA-DR = human leukocyte antigen; + = minimal 
expression; ++ = moderate expression; +++ = high expression; -- = no expression.   
  
Proliferation and polarization of allogeneic CD4+ TC in response to CSC 
exposed and/or poly I:C stimulated MDDC.  To determine the effect of CSC and poly I:C 
on DC-induced TC proliferation, MLR were performed with allogeneic (different donors) 
responder CD4+ TC confirmed by flow cytometry (FACS Canto II).  Untouched human T 
helper cells were isolated from human blood buffy coats (Florida Blood Services)  
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following isolation by Ficoll-Paque and density gradient centrifugation and MACS cell 
suspension kit, CD4+ T cell isolation kit II (Miltenyi Biotec).  The PBMCs were depleted 
of non-CD4+ TC including, CD8+ TC, gamma delta (γ/δ) TC, B cells, natural killer cells, 
DC, monocytes, granulocytes, and erythroid cells.  In order to deplete these cell types, 
PBMCs were indirectly magnetically labeled using a cocktail of biotin-conjugated 
antibodies against CD8, CD14, CD16, CD19, CD36, CD56, CD123, TCR γ/δ , and 
CD235a (glycophorinA) according to the manufacturer's instructions.  The negative 
fraction was confirmed as the CD4+ population by double positive staining for CD3 and 
CD4 by flow cytometry analysis. 
  Immature MDDC (5x105) were exposed alone or in co-culture with NHBE cells for 
various culture times and doses of CSC and Poly I:C in complete medium supplemented 
with IL4 and GMCSF.  Exposed MDDC were washed in fresh medium and treated with 
mitomycinC (20μg/mL, 45 min at 37oC) to prevent proliferation.  TC were treated with 
carboxyfluoroscein succinimidyl ester (CFSE; Molecular Probes, Invitrogen) in order to 
determine proliferation.  The protocol for CFSE staining is based on methods described 
previously (Quah, Warren, & Parish, 2007).   
  In order to determine optimal MDDC to TC ratios, 3 different ratios of MDDC in 
100 μL of medium were analyzed while the number of TC remains constant (2x105).  
Ratios were assayed in triplicate, including 1:8, 1:16, and 1:32.  MDDC were co-cultured 
with responder allogenic TC (100 μL of 1x105 cells/mL) for 4-5 days in 96-well round 
bottom microplates. 
  MLR cell culture supernatants were collected for cytokine analysis (as described 
previously) in order to determine TC polarization as Th1 (IL2, IFNγ, TNFα) or Th2 (IL4, 
IL5, IL10) as described in Table 1.  TC were harvested and analyzed by flow cytometry.   
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Controls for this assay included: unstained (no CFSE) treated TC, TC cultured alone, 
TC-treated with mitomycin C.  The positive control was MDDC cultured with TC and 
stimulated with a mitogen, phytohemmaglutinin (PHA) at a concentration of 5μg/mL. 
  The assay works by CFSE passively diffusing into the TC.  The CFSE undergoes 
esterase cleavage of the acetate groups and diffuses throughout the cytoplasm where it 
reacts with amines forming highly fluorescent conjugates that are well retained.  As the 
cells divide, the CFSE is split equally between the daughter cells resulting in diminished 
CFSE signal detection that occurs with each subsequent cell division allowing for a 
quantitative determination of the number of cell divisions. 
  
Data Analysis 
  In this 4x2 factorial design study, experiments were performed with MDDC and 
TC derived from at least four individual donors.  Data were reported as mean and 
standard error of the mean.  Each of the dependent variables were transformed by base 
10 logarithm except for DC viability (percent live), homotypic clustering (cluster score 0-
8) and TC proliferation (percent proliferation); in these three cases, raw data was used.  
Log transformation was performed in order to normalize data.  Each donor exhibited 
similar trends in data but a variation in magnitude between donors was observed.   
 Paired t- tests were conducted for two planned comparisons (see Figure 8), 
including DMSO vehicle control versus CSC high dose (CSCH) in non-stimulated and 
poly I:C stimulated co-cultures.  In order to determine level of significance and reduce 
the likelihood of a Type I error, critical alpha values were determined using a modified 
Bonferroni correction (Holland & Copenhaver, 1988).  Briefly, each test of significance 
was ranked.  The smallest observed p value was compared against a critical alpha value 
of p = 0.025 (alpha 0.05 divided by the number of planned comparisons = 2).  The 
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second test was compared against a critical alpha value of p = 0.05.  In addition, eta 
squared (t2 / t2 + degrees of freedom) values are reported to display the effect size for 
each dependent variable.  All statistics were performed with the Statistical Package for 
Social Sciences (SPSS version 15) and figures constructed with GraphPad Prism 
(Version 3.03).  In chapter four is a summary of results obtained in this study is 
presented.   
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Figure 8.  Pairwise comparisons for dependent variables. 
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Chapter Four 
Results 
Characteristics of the Sample 
 Buffy coats from a total of four individual donors were used in this study to isolate 
MDDC and TC.  Identifying data about each donor was de-identified by Florida Blood 
Services and only age and gender were given.  Two of the four donors were female and 
the average age was 38 and ranged from 21 to 60 years (21, 21, 50 and 60 years).  
Identifying data about the NHBE donor was de-identified by Lonza (Walkersville, Inc.) 
and only age and gender were given.  The NHBE donor was a 2 year old male.  Overall 
descriptive statistics of the raw data for each dependent variable are displayed in Table 
4. 
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Table 4   
 
Descriptive statistics of all dependent variables 
  
Unit of 
Measure 
 
N 
 
Minimum
 
Maximum 
 
Mean 
 
SEM 
 
Medium       
   Viability  % Live 16 86.20 98.90 97.05 0.78 
   Cluster Score  0-8 32 0.00 5.00 2.78 0.22 
   Phagocytosis  MFI 16 17223 54312 30055 2912 
   CD11c  MFI 16 40783 67670 54132 2026 
   HLA-DR  MFI 16 995 2573 1640 137 
   CD80  MFI 16 10893 39214 19305 2016 
   CD83  MFI 16 6535 20412 11142 969 
   CD86  MFI 16 13740 43733 25712 2301 
   CD54  MFI 16 28699 115052 69096 6603 
   Interleukin 6*  pg/ml 16 0.00 16.13 6.76 1.22 
   Interleukin 8*  pg/ml 16 0.00 1287 123 86.13 
   Interleukin 10*  pg/ml 16 0.00 178 52.77 12.79 
   Interleukin 12p70*  pg/ml 16 0.00 6.68 0.79 0.54 
   Tumor Necrosis Factor α∗  pg/ml 16 0.00 7.70 2.18 0.84 
   IFN-Inducing Protein 10*  pg/ml 16 0.00 17.43 2.23 1.20 
   T Cell Proliferation % Proliferation 16 23.47 55.82 37.82 2.94 
   Interleukin 2  pg/ml 16 11.88 89.02 39.78 5.99 
   Interferon γ  pg/ml 16 35.27 3841 591 239 
   Interleukin 4  pg/ml 16 32.80 725 173 43.60 
   Interleukin 5  pg/ml 16 11.27 286 88.79 20.69 
   Interleukin 10  pg/ml 16 140 3613 986 233 
   Interleukin 13  pg/ml 16 56.63 2329 860 205 
Poly I:C       
   Viability  % Live 16 73.25 96.77 90.70 1.69 
   Cluster Score  0-8 32 3.00 6.00 4.81 0.18 
   Phagocytosis  MFI 16 457 7952 2531 509 
   CD11c  MFI 16 44360 72549 62684 2399 
   HLA-DR  MFI 16 1092 2457 1741 109 
   CD80  MFI 16 29630 92959 51408 5295 
   CD83  MFI 16 4458 39609 30029 224 
   CD86  MFI 16 11005 109085 81333 5939 
   CD54  MFI 16 74106 131152 100183 4475 
   Interleukin 6*  pg/ml 16 529 3131 1837 211 
   Interleukin 8*  pg/ml 16 0.00 5178 1891 363 
   Interleukin 10*  pg/ml 16 15.57 3176 1009 262 
   Interleukin 12p70*  pg/ml 16 50.14 5935 1199 450 
   Tumor Necrosis Factor α∗ pg/ml 16 86.75 1957 492 137 
   IFN-Inducing Protein 10*  pg/ml 16 0.00 8797 2329 716 
   T Cell Proliferation  % Proliferation 16 33.44 64.92 49.02 2.60 
   Interleukin 2  pg/ml 16 21.31 286 100 22.01 
   Interferon γ  pg/ml 16 130 5022 1432 395 
   Interleukin 4  pg/ml 16 30.5 611 187 43.35 
   Interleukin 5  pg/ml 16 8.85 392 119 25.00 
   Interleukin 10  pg/ml 16 261 3984 1424 283 
   Interleukin 13  pg/ml 16 63.89 3667 1128 253 
 
Note. * = Co-culture values minus EC only culture values; SEM = standard error of the mean.   
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Experimental Conditions Do Not Affect DC Viability 
 In order to determine that CSC effects were not related to a loss in DC viability 
experiments were conducted using 7AAD staining, analyzed by flow cytometry and 
percent viable/live was calculated (Figure 9).  Descriptively, it appears there is no 
difference in DMSO vehicle versus CSCH in both non -stimulated and poly I:C 
stimulated co-cultures (Table 5).    
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Figure 9.  Dendritic cell viability.  Data presented as mean + SEM.  (7AAD staining) 
 
 
 
Table 5   
 
Dendritic cell viability  
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
Medium 
 
98.4 + 0.27 
 
94.2 +  2.7 
 
Poly I:C 93.9 +  0.28 88.4 +  3.8 
 
Note.  Data are presented as mean percent live + SEM. 
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CSC Induces Homotypic Clustering in Non-Stimulated Co-Cultures 
 None of the previous human in vitro studies described DC homotypic clustering 
following smoke exposure.  Homotypic clustering is the ability of DC to up-regulate 
adhesion molecules and cluster together and is an indicator of DC maturation 
(Delemarre et al., 2001).  In order to determine if smoke exposure induced homotypic 
clustering, light microscopy images (4x) were obtained following smoke and poly I:C 
exposures and scored as previously described.    A representative donor was chosen 
and typical clustering can be seen in Figure 10B.  A total of 8 individual donors were 
used to calculate homotypic clustering and two blinded investigators scored each 
condition based on a scoring system (Table 1) and scores were averaged.  Co-cultures 
that were not stimulated with poly I:C had a significant increase in cluster score 
secondary to CSC exposure (2.31 + 0.47 versus 3.62 + 0.26), t(3) = -3.19, p<0.025 (two-
tailed) (Figure 10C and Table 6).    In poly I:C stimulated co-cultures, clusters were 
larger and accounted for a higher percentage of DC compared to no poly I:C stimulation; 
however, there was no effect of CSC exposure (4.88 +  0.44 versus 4.75 +  0.37), t(3) = 
0.73, p>0.050 (two-tailed), as depicted in Figure 10C and Table 6.  A two-tailed test was 
performed because it was unknown if CSC or poly I:C would reduce or increase 
clustering.   
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Figure 10. Dendritic cell homotypic clustering.  Light microscopy images: A. Single dendritic cell 
(40x); B.  small cluster (20x); C. large cluster (10x); D. Light microscopy images (4X) of all 
experimental conditions from a representative donor; E. Cluster score, horizontal bar represents 
mean, * = p value < critical alpha, 0.025 (two-tailed), n = 8. 
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Table 6   
 
Dendritic cell homotypic clustering 
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
eta2 
 
t 
 
Critical    
p 
 
Observed 
p 
 
Medium 
 
2.31 + 0.47 
 
3.62 +  0.26 
 
0.59 
 
-3.19 
 
0.025 
 
 0.015* 
 
Poly I:C 
 
4.88 +  0.44 
 
4.75 +  0.37 
 
0.02 
 
0.73 
 
0.050 
 
0.732 
 
Note.  Data presented as mean cluster score + SEM.  * = p value < critical alpha 0.025, (two-
tailed), n = 8. 
 
 
CSC Reduces Phagocytosis in Non-Stimulated Co-Cultures  
 None of the previous human in vitro studies described phagocytosis of DC 
following smoke exposure.  Phagocytosis or the ability for DC to take up antigen is 
another indicator of DC maturation and function.  When a DC has taken up antigen and 
is mature, it will no longer phagocytize antigen or particulates; therefore, mature or 
maturing DC will not take up the FITC-dextran and will have lower mean fluorescence 
intensity (MFI).  In order to determine if smoke exposure affected phagocytosis, FITC-
dextran uptake was analyzed following CSC and poly I:C exposure.  The evaluation of 
FITC-dextran phagocytosis demonstrated an inhibition following CSC exposure in non-
stimulated co-cultures (4.50 + 0.08 versus 4.34 + 0.08), t(3) = 6.13, p<0.025 (two-tailed) 
(Figure 11 and Table 7).  Poly I:C stimulated co-cultures served as a positive control for 
MDDC maturation and exhibited very low MFI compared to non-stimulated co-cultures 
and there was no significant effect of CSC in poly I:C stimulated co-cultures (3.25 + 0.12 
versus 3.41 + 0.22), t(3) = -1.38, p<0.025 (two-tailed).  A two-tailed test was performed 
because it was unknown if CSC or poly I:C would reduce or increase phagocytosis.   
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Figure 11.  Dendritic cell phagocytosis.  Data were transformed by base 10 logarithm and 
presented as mean + SEM.  * = p value < critical alpha (two-tailed), n = 4. 
 
 
Table 7   
 
Dendritic cell phagocytosis  
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
eta2 
 
t 
 
Critical    
p 
 
Observed 
p 
 
Medium 
 
4.50 + 0.08 
 
4.34 + 0.08
 
0.93 
 
6.13 
 
0.025 
 
 0.009* 
 
Poly I:C 
 
3.25 + 0.12 
 
3.41 + 0.22
 
0.39 
 
 -1.38 
 
0.050 
 
0.261 
 
Note.  Data were transformed by base 10 logarithm and presented as mean + SEM.  * = p value 
< critical alpha (two-tailed), n = 4. 
 
 
CSC Induces Maturation-Associated Co-Stimulatory and Adhesion Molecules 
 Surface markers or co-stimulatory markers are essential in inducing a TC 
response and are often used as an indicator of DC maturation.  Only one study has 
investigated the effects of smoke on DC surface expression markers in vitro and in that 
study, DC were cultured alone (Vassallo et al., 2005).  This study explored the effect of 
smoke on surface expression markers in MDDC and NHBE co-cultures.  To address this 
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question, co-cultures were exposed to two doses of smoke, stimulated with poly I:C and 
surface marker expression was observed within the CD11c+ MDDC population.  The 
percent of CD11c+ MDDC ranged from 98.94% to 99.88% in all experimental conditions 
and all donors (n = 4).  As shown in Figure 12 and Table 8, smoke did not have an effect 
on CD11c or HLA-DR expression in either stimulated or non-stimulated cultures.  
Although the previous study found a reduction in surface maturation markers when DC 
were exposed to smoke, another study investigating DEP reported an increase in CD80, 
CD83 and CD86 when DC were co-cultured with EC (Bleck et al., 2006).  Therefore, it 
was speculated that maturation markers may be increased in co-culture conditions.   As 
shown in Figure 13, smoke exposure significantly increased markers CD83 (3.96 + 0.02 
versus 4.34 + 0.03), t(3) = -11.86, p<0.025 (two-tailed) in non-stimulated co-cultures.  
CD80 and CD86 followed a similar pattern but failed to reach statistical significance 
(Table 8).  This upregulation of surface maturation markers was confirmed in MDDC 
derived from four different donors.  
 No study has examined the effect of smoke on DC expression of CD54 in vitro, 
but previous reports demonstrated a reduction in CD54 expression in alveolar 
macrophages and circulating monocytes of smokers (Lensmar, Elmberger, Skold, & 
Eklund, 1998; Luppi, Lain, Jeyabalan, & DeLoia, 2007; Skold, Lundahl, Hallden, 
Hallgren, & Eklund, 1996).  Therefore, it was speculated that smoke exposure may have 
an effect on DC CD54 expression.  As shown in Figure 12 and Table 8, smoke exposure 
significantly increased CD54 expression in non-stimulated co-cultures (4.68 + 0.08 
versus 4.98 + 0.05), t(3) = -9.15, p<0.025 (two-tailed).  In all poly I:C stimulated co-
cultures, smoke did not induce significant changes of any DC surface markers (Table 8).  
A one-tailed test was performed because it was unknown if CSC or poly I:C would 
reduce or increase clustering.   
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Figure 12. Dendritic cell surface markers: Controls, CD11c and HLA-DR.  A. Unstained controls 
for each fluorochrome (FITC, APC, PE), B. Flow cytometry histograms from a representative 
donor; C. MFI data were transformed by base 10 logarithm and presented as mean + SEM, n=4.   
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Figure 13. Dendritic cell surface markers: CD80, CD83, CD86 and CD54.  A. Flow cytometry 
histograms from a representative donor; B. MFI data were transformed by base 10 logarithm and 
presented as mean + SEM, * = p value < critical alpha (two-tailed), n=4.   
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Table 8   
 
Dendritic cell surface markers 
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
eta2 
 
t 
 
Critical    
p 
 
Observed 
p 
 
Medium 
      
     CD11c 4.73 + 0.05 4.78 + 0.03 0.38   -1.36 0.050 0.265 
     HLA-DR 3.17 + 0.04 3.22 + 0.03 0.63   -2.27 0.025 0.108 
     CD80 4.18 + 0.06 4.42 + 0.09 0.72   -2.78 0.025 0.069 
     CD83 3.96 + 0.02 4.23 + 0.03 0.98 -11.86 0.025  0.001* 
     CD86 4.33 + 0.08 4.51 + 0.04 0.78   -3.24 0.025 0.048 
     CD54 4.68 + 0.08 4.98 + 0.05 0.97   -9.15 0.025   0.003* 
 
Poly I:C 
      
     CD11c 4.78 + 0.09 4.82 + 0.06 0.63   -2.25 0.025 0.110 
     HLA-DR 3.25 + 0.06 3.23 + 0.06 0.27    1.05 0.050 0.372 
     CD80 4.68 + 0.08 4.70 + 0.12 0.02   -0.25 0.050 0.819 
     CD83 4.50 + 0.04 4.53 + 0.05 0.10   -0.60 0.050 0.595 
     CD86 4.93 + 0.04 4.92 + 0.05 0.02    0.26 0.050 0.815 
     CD54 5.00 + 0.04 4.99 + 0.05 0.34    1.26 0.050 0.298 
 
Note.  MFI data were transformed by base 10 logarithm and presented as mean + SEM.  * = p 
value < critical alpha (two-tailed), n = 4.  
 
 
CSC Failed to Significantly Affect Dendritic Cell Cytokines   
 Poly I:C stimulated co-cultures produced substantial amounts of all cytokines and 
chemokines assayed as compared to non-stimulated cultures.  Although none of the DC 
cytokines were statistically different, two cytokines approached statistical significance, 
IL10 in both poly I:C and non-stimulated co-cultures and interferon inducing protein 10 
(IP10) in poly I:C stimulated co-cultures (Figure 14 and Table 9).  Smoke exposure 
increased IL10 suggesting that smoke induces DC Treg polarizing signal that could 
contribute to immunosuppressive effects.  IP10 was also increased in poly I:C stimulated 
cultures which is an important chemoattractant of Th1 lymphocytes and is an appropriate 
response to a viral stimulus.   
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Figure 14. Dendritic cell cytokines and chemokines.  Data were transformed by base 10 logarithm 
and presented as mean + SEM, n=4.   
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Table 9  
 
Dendritic cell cytokines and chemokines 
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
eta2 
 
t 
 
Critical   
p 
 
Observed 
p 
 
Medium 
      
   Interleukin 6 0.91 + 0.14 0.98 + 0.09 0.23 -0.95 0.025 0.207 
   Interleukin 8 0.69 + 0.69 0.78 + 0.78 0.00 -0.07 0.050 0.475 
   Interleukin 10 1.36 + 0.25 1.71 + 0.35 0.69 -2.61 0.050 0.040 
   Interleukin 12p70 0.00 + 0.00 0.00 + 0.00 -- -- -- -- 
   Tumor Necrosis Factor α 0.44 + 0.26 0.23 + 0.23 0.23  0.94 0.050 0.208 
   Interferon-Inducible   
     Protein 10                        
0.32 + 0.32 0.41 + 0.25 0.07 -0.46 0.050 0.338 
 
Poly I:C 
      
   Interleukin 6 3.17 + 0.14 3.21 + 0.11 0.05 -0.43 0.050 0.349 
   Interleukin 8 2.78 + 0.37 3.54 + 0.08 0.54 -1.88 0.025 0.079 
   Interleukin 10 2.37 + 0.47 2.74 + 0.39 0.75 -2.97 0.025 0.029 
   Interleukin 12p70 2.54 + 0.38 2.56 + 0.38 0.03 -0.31 0.025 0.389 
   Tumor Necrosis Factor α 2.33 + 0.26 2.63 + 0.21 0.37 -1.33 0.025 0.138 
   Interferon-Inducible   
      Protein 10 
1.97 + 0.70 3.82 + 0.04 0.70 -2.62 0.025 0.040 
 
Note.  -- = unable to calculate; Data were transformed by base 10 logarithm and presented as 
mean + SEM; critical p value (two-tailed).  
 
 
CSC Failed to Induce TC Proliferation but Enhances Th2 Cytokine Production 
 TC proliferation is an indicator of DC ability to induce an immune response to 
invading pathogens. Smoke exposed and poly I:C stimulated MDDC were co-cultured 
with allogeneic, CFSE stained CD4+ TC in mixed lymphocyte reactions (DC:TC ratios of 
1:8, 1:16, 1:32) for 4-5 days.  Figure 15A shows stained, unstained, non-proliferated and 
proliferated (PHA stimulated) controls and Figure 15B displays a representative donor of 
TC proliferation (1:16 ratio).  This study showed that despite evidence that CSC exposed 
DC are maturing (increased clustering, decreased phagocytosis, increased maturation 
markers), they do not significantly increase TC proliferation (Figure16).  Figure 16 and 
Table 10 represent pooled data from four experiments at a ratio of 1:16 (1:8, 1:32 data 
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not shown).  There was no effect of smoke on TC proliferation in non-stimulated or poly 
I:C stimulated co-cultures and no trend was observed at any DC:TC ratio.   
  Multi-plex bead assays were used to assess TC polarization by examining the 
profile (T regulatory, Th1 or Th2 type) of cytokines that are secreted by the TC co-
cultured with exposed DC.  This study showed no significant effect of CSC on the major 
Th1 cytokine, IFNγ, but did show a statistically significant increase in the proliferative 
cytokine, IL2 (1.86 + 0.20 versus 1.94 + 0.29), t(3) = -5.04, p<0.025 (two-tailed) in poly 
I:C stimulated co-cultures.  In addition, several major Th2 cytokines were upregulated 
secondary to CSC exposure in poly I:C stimulated co-cultures, including: IL5 (1.83 + 
0.28 versus 2.13 + 0.25), t(3) = -5.97, p<0.025 (two-tailed), and IL13 (2.75 + 0.28 versus 
3.07 + 0.28), t(3) = -5.61, p<0.025 (two-tailed) in poly I:C stimulated cultures.  A similar 
trend was observed in IL4 but it failed to reach statistical significance.  One of the 
primary Treg cytokines, IL10, was upregulated in poly I:C stimulated co-cultures (2.89 + 
0.22 versus 3.14 + 0.23), t(3) = -3.30, p<0.050 (two-tailed) and IL10 approached 
statistical significance in non-stimulated co-cultures (Figure 17 and Table 11).  Th1:Th2 
ratios were also evaluated and only two significant ratios were observed and only in poly 
I:C stimulated cultures including, IL2:IL5 and IL2:IL13 (Table 12).  CSC treatment 
significantly increased Th2 type cytokines (IL5 and IL13) despite the Th1 type poly I:C 
stimulus.  In addition, IL10 was increased in both poly I:C stimulated and non-stimulated 
cultures suggesting smoke exposure induces a Treg and immunosuppressive response.   
In chapter five, a discussion of the results obtained in this study is presented.  In 
addition, limitations, future directions and the significance to nursing is also discussed.  
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Figure 15.  T cell proliferation: Flow cytometry.  A.  Proliferated and unproliferated, stained and 
unstained controls, B. flow cytometry images from a representative donor.  
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Figure 16.  T cell proliferation: Percent proliferation.  Data are presented as percent proliferation + 
SEM.   
 
 
 
 
Table 10  
 
T cell proliferation: Percent proliferation 
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
eta2 
 
t 
 
Critical    
p 
 
Observed 
p 
 
Medium 
 
36.1 + 6.2 
 
 
38.6 + 5.8 
 
0.58 
 
-2.05 
 
0.025 
 
0.066 
Poly I:C 47.8 + 6.5 48.3 + 5.9 0.01 -0.14 0.050 0.899 
 
Note.  Data are presented as percent proliferated and presented as mean + SEM; critical p value        
(two-tailed).  
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Figure 17. T cell cytokines.  Analysis of Th1/Th2 cytokine profiles from mixed lymphocyte 
reactions.  Data were transformed by base 10 logarithm and presented as mean + SEM; * = p 
value < critical alpha (two-tailed), n=4. 
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Table 11  
 
T cell cytokines:  Comparison of T cell cytokine profiles 
 
Comparison 
(DMSO vs CSCH) 
 
 
Mean 1 
(DMSO) 
 
Mean 2 
(CSCH) 
 
eta2 
 
t 
 
Critical    
p 
 
Observed 
p 
 
Medium 
      
   Interleukin 2 1.50 + 0.14 1.55 + 0.16 0.24 -0.98 0.050 0.400 
   Interferon γ 2.27 + 0.29 2.36 + 0.26 0.69 -2.61 0.025 0.080 
   Interleukin 4 1.99 + 0.20 2.08 + 0.20 0.26 -1.03 0.050 0.380 
   Interleukin 5 1.65 + 0.25 1.79 + 0.24 0.54 -1.88 0.050 0.157 
   Interleukin 10 2.77 + 0.21 2.91 + 0.18 0.80 -3.46 0.025 0.041 
   Interleukin 13 2.59 + 0.28 2.67 + 0.30 0.15 -0.72 0.050 0.261 
 
Poly I:C 
      
   Interleukin 2 1.86 + 0.20 1.94 + 0.29 0.89 -5.04 0.025  0.015* 
   Interferon γ 2.69 + 0.22 3.03 + 0.35 0.51 -1.76 0.050 0.177 
   Interleukin 4 2.05 + 0.21 2.33 + 0.25 0.74 -2.89 0.025 0.063 
   Interleukin 5 1.83 + 0.28 2.13 + 0.25 0.92 -5.97 0.025  0.009* 
   Interleukin 10 2.89 + 0.22 3.14 + 0.23 0.78 -3.30 0.050  0.046* 
   Interleukin 13 2.75 + 0.28 3.07 + 0.28 0.91 -5.61 0.025  0.011* 
 
Note.  Data were transformed by base 10 logarithm and presented as mean + SEM.  * = p value 
< critical alpha (two-tailed), n = 4. 
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Table 12   
Th1/Th2 cytokine ratios  
  
DMSO 
(n=4) 
 
CSCH 
(n=4) 
 
Contrast 
p 
 
 
IL2 : IL5 
   
     Medium -0.15 + 0.24 -0.24 + 0.22 0.503  
     Poly I:C  0.03 + 0.27 -0.19 + 0.21  0.012* 
 
IL2 : IL13 
   
     Medium -1.10 + 0.31 -1.14 + 0.32 0.884 
     Poly I:C -0.90 + 0.23 -1.14 + 0.27  0.180* 
 
IFNγ : IL5 
   
     Medium 0.62 + 0.42 0.58 + 0.24 0.608 
     Poly I:C 0.87 + 0.27 0.90 + 0.25 0.901 
 
IFNγ : IL13 
   
     Medium -0.33 + 0.51 -0.31 + 0.28 0.894 
     Poly I:C -0.06 + 0.22 -0.04 + 0.18 0.946 
 
Note.  Raw data ratios were transformed by base 10 logarithm and presented as mean + SEM,  
 * = p value < critical alpha 0.025, (two-tailed), n = 4. 
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Chapter Five 
Discussion 
Summary of Findings  
 This is the first study to investigate the effects of cigarette smoke in a 
dendritic/bronchial epithelial cell co-culture model.  Since DC posses the ability to 
sample the bronchial airway, take up smoke particulates and are key mediators of 
immune response, it was reasoned that DC function and DC-induced TC response may 
be affected by cigarette smoke.  Only two studies have evaluated the effects of cigarette 
smoke on human DC function.  In these two studies, DC were cultured alone. By 
culturing DC with smoke-exposed EC, it takes into account the impact of the tissue 
micro-environment.  Therefore, this study provides insight into EC-DC interactions in 
smoke exposure and may provide evidence for disease and infection susceptibility in 
cigarette smokers; including how a smoker exposed to viral infection may respond.   
 In the context of smoke exposure only, this study indicates that cigarette smoke 
has the ability to decrease phagocytosis ability of DC and increases co-stimulatory 
maturation markers without inducing TC proliferation and inducing a potential Treg 
phenotype (Figure 18A).  IL8, a potent neutrophil chemokine was predominantly 
expressed by EC and was significantly increased in smoke exposed, non-stimulated co-
cultures.  This is an important epithelial injury signal that recruits other inflammatory cells 
into the airway and critical in vivo.     
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 DC maturation was significantly affected by CSC through a decrease in 
phagocytosis ability.  No other studies have reported an effect of smoke on phagocytosis 
ability of DC.  However, this reduction in phagocytosis was also observed in another 
antigen presenting cells, alveolar macrophages of healthy smoking subjects compared 
with non-smoking controls subjects.  In addition, phagocytosis ability was significantly 
increased in COPD subjects who had quit smoking when compared with COPD current 
smokers (Hodge et al., 2007).  DC maturation was also affected following CSC exposure 
by an increase in surface co-stimulatory markers, CD83 and CD86.  This was not 
observed in a previous study of the effects of smoke on MDDC (Vassallo et al., 2005).  
However, this difference may be attributed to the presence of EC in the co-culture as 
DEP did not effect maturation markers unless MDDC were co-cultured with EC (Bleck et 
al., 2006). Together this data suggests that smoke may induce a semi-mature DC 
phenotype and reduce the ability for DC to sample the airway for antigens.   
 CD54 is another DC surface marker that is a vital component of cell-cell 
interaction and is also a receptor for rhinovirus.   This is the first report that CSC 
significantly increased CD54 in MDDC.  Other studies have investigated the effect of 
smoke on alveolar macrophages.  However, they observed a reduction in CD54 in 
smokers in BALF and sputum (Lensmar et al., 1998; Skold et al., 1996).  It is speculated 
that CD54 may play a different role in DC versus macrophages.   
 Although CSC did not significantly affect TC proliferation rates, low levels of IL2 
may account for the lower TC proliferation observed in non-stimulated versus poly I:C 
stimulated co-cultures. The lack of TC proliferation and secretion of IL10 by MLR TC 
suggests a Treg phenotype in non-stimulated, CSC exposed co-cultures.  This may be 
attributed to low IL6, TNFα and no IL12p70 expression levels observed in DC cytokine 
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supernatants.  Together, these conditions push naïve TC to a Treg phenotype (Hammad 
& Lambrecht, 2006).    
 One possible explanation for the effects seen in CSC treated MDDC is the 
concept of tolerance or an alternatively activated DC, which is “a dendritic cell that is 
activated...resulting in a stable, semi-mature DC that can induce T-cell 
hyporesponsiveness in vitro...” (Morelli & Thomson, 2007, p. 612).  This would require 
further investigation of other characteristics of tolerogenic DC such as, expression of 
programmed cell death ligand 1 (PDL1), production of indoleamine 2,3-dioxygenase 
(IDO), resistance to innate NK-cell mediated killing and the production of IL10/TGFβ by 
TC stimulated by smoke exposed DC (Morelli & Thomson, 2007; Reis e Sousa, 2006).    
 In the context of smoke exposure and poly I:C stimulation, high levels of EC 
derived IL8 were observed along with high expression of DC maturation markers (CD80, 
CD83, CD86) adhesion molecule, CD54 and low phagocytosis.  All indicating an injured 
epithelium and activated/mature MDDC capable of producing high levels of IL6, TNFα, 
stable IL12p70 and high IFNγ (Figure 18B).  These conditions would normally lead to a 
Th1 dominant phenotype in MLR TC cytokine expression; however, an overall mixed T 
helper response was observed.  The specific effects of CSC were observed in increased 
DC IL10 (Treg polarizing) and increased IP-10 (Th1 chemokine).  The profile of TC MLR 
cytokines revealed a mixed picture of high IFNγ (Th1) and a CSC-induced increase in 
IL10 (Treg) and Th2 cytokines (IL5 and IL13).  Poly I:C is a Th1 stimulus (high IP-10, 
IL6, TNFα and stable IL12p70 expression) capable of inducing IFNγ production; 
however, CSC exposure may modulate T helper cytokine expression to increase both 
Treg cytokines (IL10) and Th2 cytokines (IL5 and IL13).   Although CSC did not 
significantly affect TC proliferation rates, higher levels of IL2 may account for the overall 
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higher TC proliferation rate observed in poly I:C stimulated versus non-stimulated co-
cultures.   
 The mixed presentation in T helper cytokines that was observed in MLR 
supernatants may be a function of DC to TC ratios.  One study reported that high DC:TC 
ratios (1:4), like the ratio used in this study (1:16), resulted in a mixed Th1/Th2 response 
while low DC:TC ratios (1:300) resulted in a Th2 phenotype (Tanaka, Demeure, Rubio, 
Delespesse, & Sarfati, 2000).  In addition, MLR reactions were carried out with CD4+ 
TC, not naïve therefore a true picture of TC polarization may not be clear due to the 
potential presence of all subtypes of T helper cells.   
 Overall, these findings suggest that DC of smokers may be less likely to mount a 
normal immune response to invading pathogens thus providing evidence for smoker 
susceptibility to infection.  It may also provide insight into how DC of smokers may 
respond to viral infection.  In addition, these findings are particularly important in patients 
with allergic airway disease since increasing Th2 cytokines would increase the risk for 
disease exacerbation.  Because DC play a critical role in modulating immune response 
to environmental agents, they have become a primary target for drug development for 
diseases that are largely mediated by environmental triggers, such as asthma and 
COPD (Kool & Lambrecht, 2007).  This study provides basic information that may be 
used in the development of therapeutic agents.   
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Figure 18. Summary of findings.  A. The effect of cigarette smoke exposure dependent variables;  
B.  The effect of cigarette smoke exposure and poly I:C stimulation on dependent variables; 
arrows indicate statistically significant increase (K) or decrease (L).   
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Limitations  
 A major strength of this study was the use of cells obtained from human subjects; 
however this is also a major limitation due to human subject variability a repeated 
measures analysis approach was used in an effort to control for this variability.  One of 
the perplexing questions regarding COPD is why some smokers develop disease while 
others do not.  In addition, there are mixed phenotypes including chronic bronchitis, 
emphysema and mixed presentations with asthma.  Therefore it is not surprising that 
some subjects would immunologically respond to smoke while others would not.  Also, 
all donor information was de-identified and there was no information regarding health 
history, medication use or smoking history and due to the limited sample size (n = 4) it is 
difficult to make general assumptions regarding the effects of smoke.  Gender and age 
of the subjects may have also played a role in the immune responses investigated and 
the heterogeneous sample may have contributed to the mixed results.  However, the 
small sample size did not permit investigation of the variation due to these demographic 
variables.  Another limitation is that the donor of the NHBE cells is different than the 
donor of MDDC and TC.  This may present an issue of self versus non-self recognition 
and result in an artificial immune response.   
 Another drawback of this study was the dose and time of CSC exposure.  This 
study used a single acute exposure and NHBE cells were exposed for approximately 36 
hours while MDDC were only exposed for 24 hours.  Other studies of DEP exposure in 
EC-DC co-cultures used a 48 hour time course.  Since this study used 24 hours, it may 
have been too early to detect late phase changes.  In addition, length of poly I:C 
exposure may have limited the amount of IFNγ secreted from MDDC.  In this study, 
MDDC were exposed to poly I:C for 24 hours and a previous study of smoke and poly 
I:C exposure in human PBMC showed minimal IFNγ following 24 hours and a significant 
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increase observed at 48 and 72 hours (Mian, Lauzon, Stampfli, Mossman, & Ashkar, 
2008).  Time course experiments need to be conducted. 
 Cigarette smoke consists of two components: vapour and particulate phases.  
CSC provides a model of the particulate phase of smoke.  There is some controversy 
that CSC is an appropriate model for smoke exposure and the need for a particle only 
control in order to distinguish specific versus non-specific effects of particulates.  Most of 
the chemicals and nicotine associated with smoke are contained in the particulate phase 
of smoke.  It is this component of smoke primarily responsible for the 
immunosuppressive effects of smoke (Nouri-Shirazi & Guinet, 2006; Sopori, 2002) and 
is therefore an appropriate model for in vitro study.  One cannot argue the value of 
controls but due to the thousands of chemicals, including tar and nicotine contained in 
CSC it can be argued that treatment effects observed are most likely due to chemicals 
rather than particulates.   
 
Future Directions 
 Further investigation into the time course effects of cigarette smoke on DC will be 
important to understand acute versus late phase immune responses.  Other surface 
markers such as CCR7, CD40/OX40L and cytokines such as TSLP/TGFβ should also 
be explored to elucidate the effects of migration, TC stimulation and Th2/Treg induction, 
respectively.  In addition, MLR experiments should be conducted with naïve TC at 
various responder ratios in order to determine true TC polarization.  Findings from this 
study can inform clinical research.  One example would be to isolate MDDC from 
smokers and non-smokers and those isolated cells exposed to cigarette smoke. 
 EC play a critical role in innate immunity by recognizing invading pathogens and 
secreting antimicrobial substances such as defensins and inflammatory/chemotactic 
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mediators such as cytokines, chemokines and leukotrienes (Bals & Hiemstra, 2004).  
Further study should focus on how smoke exposed EC not only regulate inflammation 
and the immune response but how they interact with DC through cell to cell contact and 
soluble mediators (Polito & Proud, 1998; Schleimer et al., 2007; Stick & Holt, 2003).  
This knowledge will be critical in understanding the pathophysiology of many lung 
diseases and would provide many potential therapeutic targets.  Overall, this study 
provides a sound basis for future investigation into the complex effect of smoke on DC 
and lung disease.   
 
Significance to Nursing  
 Although this study is based on basic science experiments, much of the 
knowledge obtained can be applied to nursing education, research and practice.  
Information obtained in nursing and medical research is shared.  In nursing education, 
one of the foundational courses is pathophysiology which includes immunology concepts 
therefore information obtained in this study applies to the foundation of nursing 
education.  With regards to nursing research, by nurses becoming familiar with 
immunology techniques they can incorporate these concepts in to clinical research and 
impact the progress of nursing science.  Nursing practice is affected by research through 
the incorporation of research findings into evidence-based practice.  The main goal of all 
research is to increase knowledge in order to improve our understanding of disease and 
positively affect patient care.  By understanding more about the effects of cigarette 
smoke not only do we increase pathophysiological knowledge of diseases affected by 
smoking but we indirectly impact patient care through improved diagnostics, 
therapeutics, interventions and evaluation.   
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Appendix A:  Definitions 
Adaptive immunity:  the ability of an antigen to induce antigen-specific responses in 
lymphocytes.  Adaptive immunity is characterized by an increase in response 
with exposure, memory and clonal selection of lymphocytes.   
Allergen:  an antigen that has the ability to induce a hypersensitivity or allergic reaction. 
Allogeneic:  different individuals of the same species.  
Antigen:  any molecule that can bind to an antibody.  Some have the ability to stimulate  
antibody production. 
Chemokine:  small proteins that induce the migration and/or activation of cells. 
Cigarette smoke condensate (CSC):  commercially available particulates obtained from 
burned cigarettes that are dissolved in dimethyl sulfoxide and contains many 
chemicals including nicotine and tar.  In this study, CSC was used to mimic the 
particulate phase of smoke.   
CD4:  cluster of differentiation 4 is present on thymocytes, monocytes, macrophages 
and is a co-receptor of MHC Class II.  In this study, T cells used in mixed 
lymphocyte reactions were CD4 positive.    
CD11c: cluster of differentiation 11c is present on myeloid cells and binds fibrinogen.  In 
this study, CD11c was used to identify dendritic cells in flow cytometry 
experiments.   
CD80:  cluster of differentiation 80 is present on dendritic cells and is a ligand for CD28 
on T cells.  It is important in the activation of naïve T cells through co-stimulation 
(signal 2).   
CD83:  cluster of differentiation 83 is present on dendritic, B and Langerhans’ cells.  It is 
a marker for activated dendritic cells and may assist in antigen presentation or 
cellular interactions that follow lymphocyte activation  
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CD86:  cluster of differentiation 86 is present on dendritic, monocytes and activated B 
cells and it is a ligand for CD28 on T cells.  It is important in the activation of 
naïve T through co-stimulation (signal 2).   
CD54:  cluster of differentiation 54 is present on hematopoietic and non-hematopoietic 
cells.  Also known as intercellular adhesion molecule (ICAM-1) and is involved in 
adhesion of neutrophils and is a receptor for rhinovirus.   
Cluster of differentiation (CD):  a monocolonal antibody that identifies surface molecules, 
used to identify various immune cells.    
Cytokine:  proteins made by cells that affect the function of other cells or the cell itself. 
Dendritic cell (DC):  professional antigen presenting cell and the most potent activator of 
T and B cells.  They are involved in linking the innate and adaptive immune 
systems and located in tissues exposed to the external environment such as the 
skin, lungs and intestines.  In this study, monocyte-derived dendritic cells isolated 
from human peripheral blood were used in all experiments. 
Dimethyl sulfoxide (DMSO):  a chemical compound that is a polar aprotic solvent.  It is 
an excellent solvent and cryoprotectant.  In this study, CSC is dissolved in DMSO 
therefore DMSO is used as a vehicle control in all experiments.    
Flow cytometry:  a research method that uses the principles of light scattering, light 
excitation, and emission of fluorochrome molecules to generate specific multi-
parameter data from particles and cells.  It is a technique for counting and 
examining cells or particles based on size, granularity and fluorescence.  
Homotypic cluster score:  clustering of dendritic cells with each other that is an indicator 
of upregulation of adhesion molecules and chemokines/chemokine receptors.  In 
this study, the scoring of homotypic clustering is a semi-quantitative score of 0-8.   
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Human leukocyte antigen DR (HLA-DR):  human leukocyte antigen encoded major 
histocompatibility complex, MHC class II, cell surface receptor ligand for T cell 
receptor.  It is present on antigen presenting cells with the primary function to 
present peptide antigens to the immune system for the purpose of eliciting an 
immune response. 
Innate immunity:  earliest host response to invading pathogens such as bacteria, virus 
and allergens that includes various recognition systems such as toll-like 
receptors.  The innate immune response does not increase with repeated 
exposure.   
Interferon gamma (IFNγ):  cytokine that can induce cells to resist viral replication.  It is 
produced by CD4+ Th1 cells and is a type II interferon and has antiviral, 
immunoregulatory, and anti-tumour properties. 
Interferon-inducing protein 10 (IP10):  chemokine that selectively attracts Th1 
lymphocytes and monocytes, and inhibits cytokine-stimulated hematopoietic 
progenitor cell proliferation. 
Interleukin 2 (IL2):  a T cell derived cytokine that stimulates growth and differentiation of 
T cells, B cells, NK cells, monocytes, macrophages.  A central cytokine in the 
development of an adaptive immune response.   
Interleukin 4 (IL4):  a cytokine that is secreted by Th2 cells.  It enhances both secretion 
and cell surface expression of IgE and IgG1. An important cytokine in allergic 
disease and has overlapping functions with IL13.   
Interleukin 5 (IL5):  secreted by Th2 and mast cells that is a key mediator in eosinophil 
activation. An important cytokine in allergic disease.   
Interleukin 6 (IL6):  both a pro-inflammatory and anti-inflammatory cytokineimportant 
mediators of fever and of the acute phase response and secreted in response to 
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activation of the innate immune system.  High IL6 It is associated with both Th1 
and Th2 responses and low IL6 is associated with Treg responses.   
Interleukin 8 (IL8):  inflammatory chemokine produced by many cell types.  Mainly 
functions as a neutrophil chemoattractant. 
Interleukin 10 (IL10):  secreted by Th0 cells blocks cytokine synthesis by Th1 cells 
Interleukin 12p70 (IL12p70):  Th1 polarizing type cytokine secreted mainly by dendritic 
cells.  Induces IFNγ production and proliferation/differentiation of Th1 cells.   
Interleukin 13 (IL13):  secreted by Th2 cells, involved in the upregulation of IgE secretion 
by B cells.  An important cytokine in allergic disease.   
Ligand:  general term for a molecule recognized by another structure such as a receptor. 
MHC Class II:  major histocompatibility complex class II present on antigen presenting 
cells with the primary function to present peptide antigens, both self and non-self, 
to lymphocytes for the purpose of eliciting an immune response.  Specifically, 
MHC class II presents antigen fragments to T-helper cells by binding to the CD4 
receptor on the T-helper cells. 
Mixed lymphocyte reaction (MLR):  When lymphocytes for two different individuals are 
cultured together.  In this study, CSC/poly I:C exposed dendritic cells were co-
cultured with allogeneic CD4+ T cells for 4-5 days.   
Monocyte-derived dendritic cells (MDDC):  dendritic cells obtained by culturing CD14+ 
monocytes with granulocyte-macrophage colony-stimulating factor (GM-CSF) 
and interleukin 4 (IL4).  Used in this study as the dendritic cell model.   
Normal human bronchial epithelial cells (NHBE):  commercially available primary cell 
culture of bronchial epithelial cells from human donors.  Used in this study as the 
bronchial epithelial cell model.   
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Phagocytosis:  the engulfment of particles, bacteria, cell debris, etc. by cells.  A 
characteristic function of cells such as macrophages and dendritic cells.  In this 
study, phagocytosis is assessed by FITC-dextran uptake by dendritic cells and 
analyzed by flow cytometry.  Data is presented as mean fluorescence intensity 
(MFI).  A low MFI is associated with a mature dendritic cell and a high MFI is 
associated with an immature dendritic cell.   
Polyinosinic-polycytidylic acid (Poly I:C):  a commercially available synthetic double 
stranded RNA.  A toll-like receptor 3 ligand that mimics viral infection and 
induces a Th1 response.  In this study, poly I:C is used as a positive control for 
dendritic cell maturation  
Polarizing cytokine:  a cytokine that induces a specific phenotype in the target cell.   
T cells (TC):  thymic lymphocytes that developed in the thymus. 
T cell proliferation:  In this study, TC proliferation is assessed by CFSE staining and 
analyzed by flow cytometry.  Data are presented as percent proliferated.   
Naïve T helper lymphocyte (Th0):  T lymphocytes that have never engaged a specific 
antigen.  They are different from effector and memory T cells. 
T helper type 1 lymphocyte (Th1): T lymphocyte characterized by the cytokines they 
produce (IFNγ). An increase in Th1 cytokines are associated with autoimmune 
diseases.   
T helper type 2 lymphocyte (Th2):  T lymphocyte characterized by the cytokines they 
produce (IL4, IL5, IL13).  An increase in Th2 cytokines are associated with 
allergic diseases.   
T helper type 17 lymphocyte (Th17):  T lymphocyte characterized by the cytokines they 
produce (IL17).   
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Toll-like receptor 3 (TLR3): one of the innate immune systems recognitions systems.  It 
is one of the toll-like receptors that recognizes double stranded RNA of viruses.   
T regulatory lymphocyte (Treg):  T lymphocyte characterized by the cytokines they 
produce (IL10, TGFβ).  They have the ability to inhibit T cell responses and 
induce tolerance. 
Tumor necrosis factor alpha (TNFα): a pleiotropic inflammatory cytokine involved in 
apoptotic cell death/proliferation, differentiation, inflammation, tumor growth, and 
viral replication.  It is important in both Th1 and Th2 polarization, acute phase 
reactions and fever.   
Viability:  to be alive.  In this study, viability was assessed by 7-AAD staining and 
analyzed by flow cytometry.  Data are presented at percent live.   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
About the Author 
 
 Alison Jones Montpetit was born and raised in Decatur, Alabama.  She attended 
the University of North Carolina at Wilmington where she obtained a Bachelor’s degree 
in nursing in 2001.  She practiced nursing in the Medical Intensive Care Unit at New 
Hanover Regional Medical Center.  In 2002, she moved to Tampa, Florida to pursue the 
BS-PhD program at the University of South Florida.  During her tenure, she completed a 
Master’s in nursing (2004) and attended the Summer Genetics Institute at the National 
Institute of Nursing Research (2004).  She is married to Marty Louis Montpetit, PhD and 
expects her first child in August of 2008. 
